NEW YORK (GenomeWeb) – Illumina and Cornell University have jointly agreed to dismiss a patent dispute that originated in 2010, according to documents filed with the US District Court for the District of Delaware.

Cornell and Life Technologies (now part of Thermo Fisher Scientific) sued Illumina in May 2010, claiming that Illumina's microarray products infringed on eight patents held by Cornell and exclusively licensed to Life Tech.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

May
01
Sponsored by
Horizon Discovery

This webinar will provide an in-depth case study demonstrating how reference standards can be used to develop and validate circulating tumor DNA (ctDNA)-based assays.

May
08
Sponsored by
Dovetail Genomics

This webinar will discuss a proximity ligation-based method for studying structural variation in formalin-fixed paraffin-embedded (FFPE) tissue.